GENinCode plc

Company Profile

Company website
Medical Equipment and Services (Medical Services)
GENinCode plc (AIM: GENI) is engaged in the risk assessment, prediction and prevention of cardiovascular disease (“CVD”). CVD is the leading cause of death worldwide accounting for approximately 18 million deaths annually.

Investor Access

20 Sep
Event information

The Company will be announcing its interim results for the six months ended 30 June 2023 on Wednesday 20 September 2023.

Investors can sign up to Investor Meet Company for free and add to meet GENinCode PLC via the following link:
Wednesday 20 September 2023 at 4:30pm
Financial Calendar
 Event Date
Year EndDecember 31
Half  Year End30 June
Preliminary Results*March/April
Interim Results*September

* Months based on previous announcements of this kind